Legacy Pharmaceuticals

Activities: Manufacturing Pharmaceutical

Legacy Pharmaceuticals Switzerland is a Swiss contract manufacturer and service provider (Contract Manufacturing Organization) for the global pharmaceutical industry. Created in 2007 with the acquisition of certain products and our Basel manufacturing site, our roots go back to 1947, back to the years when the modern Swiss pharmaceutical industry was just getting started.

Trending Articles

  1. Lonza Capsules & Health Ingredients expands capsule manufacturing capacity in India and China New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari (IN) and Suzhou (CN), highlighting the long-term strategic commitment to...
  2. IDT opens molecular biology research facility in Redwood City Dr Caifu Chen to lead new product development at California site
  3. Novo Holdings completes acquisition of Catalent Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    Industrial data mastery: navigating the 2025 landscape As industrial manufacturers contend with the ever-increasing volume and variety of operational data, the year ahead promises both complexity and opportunity
  5. Discover a new standard in self-priming pump technology Alfa Laval offers hygienic pumping with more efficiency and less noise

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

Related Content

Media

COVID-19 and its effect on current and future pharmaceutical industry trends

As well as the ongoing efforts to find a treatment and a vaccine, COVID-19 will also drive the pharmaceutical industry to shorten its global supply chains through increased inventories and local manufacturing, says Michael Danzi, CEO, Legacy Pharmaceuticals
Manufacturing

Legacy Pharmaceuticals implements new customer service software in Switzerland

SAP S/4 HANA software has been implemented for all 250 employees
Manufacturing

Swiss CMO sets employee expansion goals

Legacy Pharmaceuticals has set a goal of 250 employees by year end in response to increasing demand for one-stop-shop drug products manufacturing services
Packaging

Legacy ramps up preparations for Russian track-and-trace regulations

Swiss pharma supplier has installed and certified new Bosch serialisation and aggregation equipment on three packaging lines
Containment

Legacy Pharmaceuticals announces long-term lyophilisation strategy

A lyophilisation suite is in the works, with closed RABS filling line technology, 2 to 3 freeze-driers up to 30 sqm each and automated load and unloading systems
Manufacturing

Legacy improves AntiViral drug with SCHOTT Type I plus vials

Legacy Pharmaceuticals and SCHOTT are now offering a solution to future customers with a need to provide better stability, particularly for highly sensitive formulations
Media

Developments and the future of pharmaceutical packaging

With the global primary packaging market in the pharmaceutical sector expected to experience remarkable growth during the next few years, Dr Kevin Robinson asked a number of industry experts to comment on the hurdles, drivers and emerging trends that are influencing how drugs are formulated, packaged and delivered
Subscribe now